Clinicopathological differences between EGFR mutated and EGFR wild-type lung adenocarcinoma with papillary predominant pattern. Goto E, Taki T, Nomura K, Miyakami Y, et al. Lung Cancer 2024;192:107830.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Goto E, Taki T, Nomura K, Miyakami Y, et al. Clinicopathological differences between EGFR mutated and EGFR wild-type lung adenocarcinoma with papillary predominant pattern. Lung Cancer 2024;192:107830.
PMID: 38805901